GLP-1S 15mg
GLP-based research peptide studied for incretin receptor signaling, glucose-regulation pathways, and metabolic system models.
Compound Overview
GLP-1S is a glucagon-like peptide–based analogue studied in laboratory environments for its interaction with GLP-1 receptors and associated incretin signaling pathways. GLP-1 receptor activation is linked to glucose-dependent regulatory processes, insulin signaling modulation, and gastrointestinal hormone pathway activity.
In controlled research models, GLP-1 analogues are examined for their role in metabolic regulation systems, appetite-related signaling cascades, and pancreatic beta-cell response pathways. Experimental designs often evaluate receptor binding dynamics, downstream intracellular signaling mechanisms, and coordinated endocrine feedback interactions.
Receptor Activity
Targets GLP-1 receptors involved in incretin signaling, glucose-regulation pathways, and metabolic system research.
Metabolic Research Focus
Commonly studied in laboratory models examining insulin-glucose interaction, appetite signaling pathways, and endocrine regulation systems.
Laboratory Classification
Classified as a GLP-based research peptide analogue for experimental and analytical applications.
Product Specifications
- Product Name: GLP-1S
- Peptide Type: GLP-1 analogue
- Quantity: 15mg per vial
- Form: Lyophilized peptide powder
- Intended Use: Research use only









Reviews
There are no reviews yet.